comparemela.com

Latest Breaking News On - Division of gynecologic oncology - Page 4 : comparemela.com

Dr Thaker on the RAMP-301 Trial of Avutometinib/Defactinib in Low-Grade Serous Ovarian Cancer

Premal Thaker, MD, MS, discusses the phase 3 RAMP-301 trial of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer.

Dr Modesitt on Shared Decision-Making When Choosing PARP Inhibitors in Ovarian Cancer

Susan C. Modesitt, MD, FACOG, FACS, discusses the role of PARP inhibitors in the treatment of patients with ovarian cancer.

Providing Trauma-Informed Oncologic Care to Sexual and Gender Minority Patients

A diagnosis of cancer and subsequent treatments may create traumatic experiences for sexual and gender minority patients that require a trauma-informed care approach. Cancer and its treatment can be traumatic for sexual and gender minority patients, requiring a trauma-informed care approach.

Providing Trauma-Informed Oncologic Care to Sexual and Gender Minority Patients

Sexual and gender minority (SGM) patients are more at risk for experiencing trauma than their cisgender heterosexual counterparts. A diagnosis of cancer and its subsequent treatments may create traumatic experiences for SGM patients that require a trauma-informed care approach. Cancer and its treatments can be traumatic for sexual and gender minority patients, requiring a trauma-informed care approach.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.